Navigation Links
Womb transplantation- to be successful in 2 years’ tim

The British doctors are hopeful that the world's first successful womb transplant operation will be carried out by them within 2 years.//

Women unable to have children because they are born without a uterus or have had to have an emergency hysterectomy will be benefited from this operation.

A new method to provide a transplanted womb with a reliable blood supply has been developed by a team of researchers at London, New York and Budapest.

In 2000, a 26-year-old Saudi woman underwent the world's first uterus transplant. But the operation failed when a clot developed in the blood vessel supplying the organ. This was the major problem, which has been overcome by the new procedure. It has been successful in animals and can be performed successfully in humans also.

Richard Smith, a consultant gynaecologist at Hammersmith Hospital in west London, said: "By getting to a place where we seem to have a reliable method of giving the uterus a blood supply, that takes us a whole heap closer to being able to provide this for humans."

Mr Smith and his team have been working on the project for eight years. They hope that transplantation of a womb from a dead donor to a woman unable to conceive will be possible soon.

He said: "We are relatively close. I think that two years probably is realistic. Two other groups of researchers - in Saudi Arabia and Sweden - are also working on human womb transplants. Already 30 women, most of them British, have expressed an interest in undergoing the procedure”, Mr Smith said.
GYT
'"/>




Page: 1

Related medicine news :

1. Endangered species may be successfully cloned in another animals womb
2. Indian Prime Minister has successful Knee Replacement Surgery
3. Hope for Marburg treatment: vaccine successful in primates
4. Down syndrome simulated in animal model after successful chromosome transplantation
5. AIDS bias successfully overcome by Indian Muslims in South Africa
6. Hunt for Common Genes linked to Cancer Expected to be Unsuccessful
7. China’s AIDS vaccine-successfully finishes first phas
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer ... stages, is more than 95%. Once the cancer spreads to other organs, bones, or ... find out how to avoid this latter group, tune in to Lifestyle Magazine ...
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... ... at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate ... and will be an opportunity for area-residents to celebrate two great years while ...
(Date:3/25/2017)... PA (PRWEB) , ... March 25, 2017 , ... Getting ... as a public relations partner. , All through the year, Garden Media aims ... press releases, working with key influencers and pitching client’s key messages to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
Breaking Medicine Technology: